HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe

CMS CPAP Coverage Timeline

May 13, 2008 by HME Business

1986
•    After conducting a study, the Office of Health Technology Assessment (OHTA) recommended that Medicare should cover CPAPs when used in adult patients with severe to moderate OSA who couldn’t obtain relief from other non-invasive therapies.

1989
•    Medicare adopted OHTA’s recommendations on the diagnosis of OSA and issued a NCD that covered CPAP for adult patients with moderate or severe OSA.
•    CMS reviews unattended Home Sleep Study.

1995
•    CMS’s reviewing body for the development of NCD’s concluded that the safety and effectiveness of home studies used to diagnose sleep disorders were unproven and should not be covered by Medicare.
•    The committee recommended that the issue be revisited for national policy following the completion of a study of sleep disorders conducted by the National Institute of Health. The study was expected to be complete in two to three years. The coverage of unattended HST was left to the discretion of the carrier.

2001
•    The national coverage policy on CPAP was expanded to include Medicare beneficiaries with an apnea-hypopnea index > 15, or an AHI > 5 and < 14 with documented symptoms of excessive daytime sleepiness, impaired cognition, mood disorders or insomnia or documented hypertension, ischemic heart disease or history of stroke.
•    The policy specified that only PSG done in a facility-based sleep study lab could be used to identify patients with OSA.

2005
•    CMS determined that evidence was not adequate to conclude that the use of unattended portable multi-channel sleep testing with a minimum of 7 monitored channels including EEG, EOG, EMG, ECG or heart rate, airflow, respiratory effort and oxygen saturation was reasonable and necessary in the diagnosis of OSA and the test remained uncovered.

2007
•    CMS receives a request to reconsider the 2005 NCD for CPAP Therapy for OSA to allow coverage of CPAP based upon a diagnosis of OSA by home sleep testing.

2008
•    CMS released its final rule on home sleep testing that expanded coverage for home sleep testing devices II, III, and IV for the diagnosis of obstructive sleep apnea.

Source: Centers for Medicare and Medicaid Services

Related Articles Read More >

ACU-Serve Names President to Lead Growth, Innovation
Natasha Baria Mehta has more than 25 years of RCM expertise and experience in healthcare settings.
VieMed Reports Sleep Apnea, Maternal Health Segment Gains in Q1 Earnings Call
The supplier also provided an update on how the new NCD for ventilation is impacting patients.
CQRC Responds to RFI for CRUSH Comments
The Council for Quality Respiratory Care recommended using technology-based systems and improving audit and appeals processes’ transparency.
Proposed Rule Would Change Surety Bond Amounts for RID Competitive Bidding
The bond amount would jump to $100,000 for suppliers wishing to compete for remote item delivery (RID) contracts.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe